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Nosocomial and community transmission
of measles virus genotype D8 imported by a
returning traveller from Nepal
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Abstract
Measles is uncommon in Australia due to effective national vaccination strategies. In mid-2003, a cluster
of nine cases of measles occurred in western Sydney. The index case was a 29-year-old traveller recently
returned from Nepal. The case presented to hospital and transmitted the disease to two others in the
Emergency Department. Further cases resulted from both community and nosocomial transmission.
The median age of cases was 24 years, with three cases in children aged under four years. Only one
person had a documented history of measles vaccination, a child who had received one dose of vaccine
overseas. One case was a 2-month-old infant whose mother was immune and two cases were hospital
staff members. Molecular analysis of measles virus isolates from four cases revealed the same D8 genotype, a strain previously identified in Nepal. Staff vaccination strategies implemented as a result of the
outbreak were poorly patronised despite nosocomial transmission. As diseases such as measles become
rare it is important to thoroughly investigate any outbreaks, and to maintain a high index of suspicion
of measles, particularly in travellers presenting with a rash having returned from measles-endemic
areas. Genetic analysis is important in tracing the origins of an outbreak, and to confirm relatedness
between cases. The highly infectious nature of measles virus also underscores the need for appropriate infection control in minimising risk of nosocomial transmission. Such policies are of increasing
importance with the emergence of novel viruses or the threat of pandemic influenza. Commun Dis Intell
2006;30:358–365.
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Introduction
Measles is a highly infectious and serious disease
responsible for significant morbidity and mortality in
undeveloped countries.1 In Australia, locally acquired
measles is now uncommon, largely due to effective
measles vaccination initiatives. Outbreaks are most
often due to overseas acquisition of the virus with
subsequent infection of susceptible individuals in
Australia2,3 or spread through conscientious objectors to vaccination.4
The reported incidence of measles has declined
since the introduction of surveillance in 1991, to a
record low level of 0.07 cases per 100,000 population in 2005.5 While possible cases presenting with
a measles-like rash are sometimes reported to the

local public health unit (PHU) by general practitioners and hospital physicians, the majority of reported
cases do not fit the case criteria for measles as
defined by the NSW Health Department.6 Moreover,
confirmatory diagnostic testing is not ordered for
most patients who present with a rash, confounding
accurate determination of the incidence of vaccine
preventable diseases such as measles and rubella
in Australia.
Following the National Measles Control Campaign in
1998, immunity to measles amongst children aged
6–11 years in Australia increased from 84 per cent
to 94 per cent.7 However, there remains a high-risk
population of young adults in Australia, born between
1975 and 1981, who may have not contracted measles during childhood due to its declining incidence,
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but who also may not have been vaccinated due to
lower vaccine coverage at the time.8 This population
of young adults is therefore at risk of measles, as
demonstrated in four outbreaks in Victoria, occurring
between 19999 and 2003.3 Such outbreaks amongst
a susceptible population reinforce the need for continued surveillance and follow-up of cases of measles, rapid testing, and the maintenance of a high
index of suspicion for measles amongst travellers
presenting with a rash. In three of the outbreaks,
the index case acquired measles overseas and
imported the disease into Australia. The index case
for the remaining outbreak was not identified.3
Outbreaks of measles can be characterised by
genetic analysis of virus isolates. Sequence analysis
of the haemagglutinin (H) gene and of the hypervariable region of the nucleoprotein (N) gene can help
in identifying geographic sources of the disease,
particularly in countries with few locally acquired
cases and where effective immunisation strategies
are in place. Studies in Canada, the United States of
America and Australia have shown that the measles
virus genotypes found in the outbreaks described
in the reports resulted from importation of the virus
rather than local acquisition.10,11,12 Genetic relatedness between cases and reference to known strains
is an important part of an outbreak investigation,
and can assist in informing eradication and control
strategies.
This paper describes a cluster of nine cases of measles in western Sydney that presented in mid-2003.
The genetic analysis of the measles virus obtained
from specimens, the role of transmission through
the hospital Emergency Department, and the importance of vaccination are discussed.

Methods
Case definition
The case definition for a confirmed case of measles was clinically defined measles-like illness
with laboratory confirmation by one of the following: detectable measles virus-specific IgM or IgG
seroconversion in serum, detection of measles
virus antigen by immunofluorescence or measles
virus RNA by polymerase chain reaction (PCR) from
respiratory swabs or serum, or isolation of measles
virus from blood, swabs or aspirates. Symptoms
of clinically-defined illness included rash, cough,
coryza and temperature over 38°C.6
Outbreak investigation and contact tracing
PHU officers investigating the outbreak followed
response protocols outlined in the NSW Health
Notifiable Diseases Manual.6 Local general practitioners, infectious diseases physicians and emer-
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gency departments were alerted and provided with
information about isolation and laboratory testing
of suspected cases. PHU staff undertook contact
tracing of patients following presentations to the
Emergency Department (3 cases) and a general
practice (2 presentations by one case). If the period
of time from exposure to follow-up was short enough
for vaccination or immunoglobulin prophylaxis to be
effective, adults aged between 18 and 32 years
were advised to receive measles, mumps and
rubella (MMR) vaccination, and children aged under
12 months were offered immunoglobulin. These age
groups were targeted as being susceptible to measles as the adults may have not contracted measles
during childhood or not have been vaccinated, and
the infants were too young to have received the
first dose of MMR vaccine. Older children who had
not received two doses of MMR vaccine were also
advised to be vaccinated.
Hospital Infection Control staff contacted staff members at the hospital who were exposed to an infectious case. Those aged 32 years or younger were
advised to receive MMR vaccination.
Laboratory diagnosis
Nasopharyngeal specimens, or nose and throat
swabs, were collected from patients presenting with
clinically-defined measles-like illness. For measles
antigen detection, acetone-fixed smears of swabs
were stained with measles-specific monoclonal antibodies (Chemicon International, Temecula, USA) and
fluorescein isothiocyanate-conjugated anti-mouse
immunoglobulin in an indirect immunofluorescence
assay.
Vero cell monolayers in tube cultures were inoculated with 0.2 ml suspension of respiratory tract
samples, incubated at 37°C and observed daily for
cytopathic effects (CPE) characteristic of measles
virus. Cultures showing CPE were confirmed by
staining with measles-specific monoclonal antibodies described above.
A diagnostic measles PCR was performed using
nucleoprotein (N) region primers in a nested format
(outer sense 5’TACCCTCTGCTCTGGAGCTATGCC3’,
outer antisense 5’CTCGCACCTAGTCTAGAAG3’ and
inner sense 5’TATCACTGCCGAGGATGCAAG3’, inner
antisense 5’TGTCTGAGCCTTGTTCTTCCG3’). Total
RNA was extracted from 200 μl serum using the
Roche High Pure RNA kit (Roche Diagnostics,
Germany). First round amplification was performed
using Hot Start Amplitaq gold DNA taq polymerase
and buffer (Applied Biosystems, Branchburg, New
Jersey, USA) supplemented with 2.0 mM MgCl2,
0.2 mM of each dNTP, 0.2 μM of both primers and
cycling profiles of denaturation at 95°C (1 minute),
annealing at 53°C (40 seconds), and extension at
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72°C (1 minute) for 30 cycles. For the nested PCR,
1 μl of the outer product was amplified under similar
conditions, except with an annealing temperature
of 61°C. PCR amplicons of 379 nucleotides were
visualised by electrophoresis on 1.5 per cent agarose gel, followed by sequencing for confirmation
and comparison to other outbreak and reference
measles sequences.12,13

from serum and swabs was eluted in 50 μl and
from infected Vero cells in 100 μl of elution buffer.
A 456-nucleotide (nt) sequence coding for the carboxy-terminal of the nucleoprotein (N) gene and the
full length (1,854 nt) of the haemagglutinin (H) gene
were amplified in a single round PCR from four isolates. Amplicons were sequenced in both directions
using sequencing primers described elsewhere.14

Testing for measles-specific IgM and IgG serum antibodies was performed using the Enzygnost (Dade
Behring, Germany) enzyme immunoassay according to the manufacturer’s instructions.

Nucleotide sequences of the N and H genes were
aligned using the Clustal W (1.7) program and phylogenetic trees were generated by the Phylip program
(Phylogeny Inference Package version 3.5) using the
DNA distance matrix program (version 3.57) followed
by neighbour-joining tree. Treeview (version 1.5) was
used to draw the unrooted trees. Access to these programs was through www.angis.org.au, the website
of the Australian National Genomic Information
Service (ANGIS). The reference measles strains and
Genbank Accession numbers used in the phylogenetic analyses are listed in the Table.12,13

Measles virus genotyping
For measles genotyping, total RNA was extracted
using the Roche High Pure RNA kit (Roche
Diagnostics, Germany) from either the swab samples, or from 200 μl of serum or Vero cells infected
with measles virus harvested when CPE involved
at least 30 per cent of the cell monolayer. RNA

Table.

Measles genotypes used for the genetic characterisation of the outbreak isolates

Reference strain

Genotype

Haemagglutinin gene,
Genbank Accession no.

Nucleoprotein gene,
Genbank Accession no.

A

U03669

U01987

Yaounde.CAE/12.83

B1

AF079552

U01998

Libreville.GAB/84

B2

AF079551

U01994

Ibadan.NIE/97/1

B3

AJ239133

AJ232203

New York.USA/94

B3

L46752

L46753

Tokyo.JPN/84/K

C1

AY047365

AY043459

Erlangen.DEU/90

C2

Z80808

X84872

Maryland.USA/77

C2

M91898

M89921

Edmonston-wt.USA/54

Bristol.UNK/74 (MVP)

D1

Z80805

D01005

Johannesburg.SOA/88/1

D2

AF085198

U64582

Illinois.USA/89/1

D3

M81895

U01977

Montreal.CAN/89

D4

AF079554

U01976

Palau.BLA/93

D5

L46757

L46758

Bangkok.THA/93/1

D5

AF009575

AF079555

New Jersey.USA/94/1

D6

L46749

L46750

Victoria.AUS/16.85

D7

AF247202

AF243450

Illinois.USA/50.99

D7

AY043461

AY037020

Manchester.UNK/30.94

D8

U29285

AF280803

Janakpur.NEP/2.99/1

D8

AJ250061

AJ250069

Victoria.AUS/12.99

D9

AY127853

AF481485

Kampala.UGA/3.01

D10

AY923214

AY923203

Goettingen.DEU/71

E

Z80797

X84879

Madrid.SPA/94 SSPE

F

Z80830

X84865

Berkeley.USA/83

G1

AF079553

U01974

Amsterdam.NET/49.97

G2

AF171231

AF171232

Gresik.INO/17.02

G3

AY184218

AY184217

Hunan.CHN/93/7

H1

AF045201

AF045212

Beijing.CHN/94/1

H2

AF045203

AF045217
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Results
Outbreak details
Details of the outbreak are shown in Figure 1. The
index case, Case 1, a 29-year-old male, presented
to the Emergency Department of a large teaching
hospital in June 2003 with a three-day history of
fever, cough and feeling unwell. He presented with
a morbilliform rash, fever, cough, coryza and temperature over 38°C. He was asked to return the next
day whereupon his condition had worsened and he
was admitted. The case had returned from Nepal via
a stop-over in Bangkok seven days before his first
presentation. A travel history was taken on admission and a number of conditions considered. The
case claimed to have had measles previously and to
have been vaccinated against measles in the past.
He had not been vaccinated with MMR immediately
prior to the trip to Nepal. Measles was considered
as a possible diagnosis upon his first presentation
and he was isolated. Upon his second presentation,
however, no specific infection control procedures
were implemented. The local PHU was not notified
and a public holiday long weekend provided an
additional delay before measles was confirmed.

Figure 1.

The 3½-year-old child (Case 6) visited a church
whilst infectious and transmitted measles to an
unvaccinated adult (Case 8, aged 24 years) who
developed a rash 14 days after contact. An additional case (Case 9, aged 21 years), living in the
same geographical area as the other cases, was
notified to the local PHU prompting investigation of
possible exposures. If Case 9 was linked to any of
the other cases, the timing of symptoms indicated
that infection could only have been through contact
with Case 8. However the nature of any such contact could not be determined. It is possible that other
cases occurred in the area but were not diagnosed
as measles or were not notified.
The median age of cases was 24 years (range
2 months to 38 years), with three cases in children
aged under 4 years.

Transmission of measles between cases
Clinical and laboratory details

Index case
Case 1
(traveller returned
from Nepal)
EMERGENCY DEPT EXPOSURE
Case 2
(baby of case 3)

Case 3

Case 4
(child of case 3)

EMERGENCY DEPT EXPOSURE
Case 5
(ED staff member)

OCCUPATIONAL EXPOSURE
Case 7
(hospital worker)

Case 6
(child attending ED)

CHURCH EXPOSURE
Case 8

Case 9
(linked geographically)

Upon confirmation of measles, Emergency Department contacts of Case 1 were notified of the risk of
measles. It was too late for immunoglobulin prophylaxis. Two contacts from the one family (Cases 2
and 3, aged 2 months and 27 years respectively)
developed measles with the rash appearing between
8 and 16 days post-contact. Case 3 was the father
of Case 2. Subsequently, measles was transmitted
to a 15-month-old sibling of Case 2 (Case 4) who
was not vaccinated against measles. The 17-yearold mother, whose immune status was indicated by
measles-specific IgG in a serum sample, did not
contract measles.

CDI

Case 3 presented to the Emergency Department
and, despite being promptly isolated, transmitted the
infection to an Emergency Department staff member
(Case 5, aged 30 years) and a 3½-year-old child
(Case 6) who was being treated in the Emergency
Department. Both developed a rash 11 days after
contact. Another staff member subsequently developed measles (Case 7, aged 38 years), the likely
source being Case 5.
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All cases except the infant (Case 2) presented with
rash, fever, and cough. The infant presented with
rash, fever and coryza. Koplik spots were detected
in four patients. Six patients also presented with
conjunctivitis. Abnormal liver function tests were
noted in all adult cases tested (n=4), an uncommon
manifestation of measles.15 All patients had at least
one laboratory test confirming measles virus infection. All cases were confirmed cases according to
NSW Health criteria.6 Four of the six adult cases and
one of the three child cases required hospitalisation
for between two and five days.
The incubation period of the infant’s illness (Case 2)
was short, with the rash occurring eight days postcontact. The period between contact and rash for
the 3½-year-old child (Case 6) was 11 days. The
other child (Case 4) contracted measles from
Case 3 or Case 2 and the exact date of transmission
was unknown. The adults for whom precise details
of contact were known developed a rash between
11 and 16 days post-exposure.
Vaccination status
Only one person (Case 6) had documented evidence
of measles vaccination, having received a dose of
vaccine overseas. The other two children in the outbreak were unvaccinated either because they were

361

Article

too young (Case 2) or parental choice (Case 4). Of
the six adult cases, three thought they had received
one dose of vaccine (Cases 1, 3, 9), two thought
they had measles in childhood (Cases 1, 8) and one
thought that measles serology had been previously
tested and that immunity was adequate (Case 5).
No details of the vaccination or disease history were
obtained for Case 7.
Outbreak investigation
A total of 496 people were identified as possible contacts at either the Emergency Department or general
practitioner (GP) surgery. Of these, 184 contacts from
the Emergency Department and 72 contacts from the
GP surgery were in the ‘at risk’ age group of 18 to
32 years, or were infants aged under 12 months.
Telephone contact was made with 61 per cent of the
Emergency Department contacts and with 52 per
cent of the GP surgery contacts. A letter was sent to
the remainder. All contacts were provided with advice
about the risk of measles and disease symptoms,
and were recommended vaccination if necessary.
There was difficulty in tracing all contacts presenting
to both the Emergency Department and the general
practice as some patients had not provided any or
accurate contact details on presentation. PHU officers
attempted to visit two families who could not be contacted by telephone, to advise parents about the need
for immunoglobulin prophylaxis for exposed infants.
One family was contacted in this way, while the other
family had moved and could not be located.

six per cent of those targeted indicated they had
previously been vaccinated. A second staff health
program, aimed at staff who did not respond to the
first program and at new staff, identified 461 staff. Of
these, three per cent had been previously vaccinated
(14 people) and 14 per cent (63 people) received
MMR. Ten per cent declined vaccination and 74 per
cent did not respond to the program.
Genetic analysis of measles viruses
Measles virus was isolated from five patients
(Cases 2, 3, 5, 7 and 8) including two cases from
the same family. Sequencing of the N genes of
four isolates (only one isolate from the family was
sequenced) showed that they were identical, and
were more closely related to a Nepalese measles
genotype D8 (Janakpur NEP/2.99/1, Table) isolate16
than to other sequences, (Figure 2).12,13 Similar
results were obtained with phylogenetic analysis
of the H gene sequences (data not shown). The
D8 genotype has occasionally been detected in
Australia previously (the last time in early 2001),
although the country of origin was not always available.17 The D8 genotype was confirmed on RNA
from three isolates sent to the Measles Reference
Laboratory at VIDRL (Doris Chibo, personal communication). To confirm the specificity of the diagnostic PCR compared to measles virus isolation and
antigen detection from respiratory tract specimens,
a 355 nt sequence of the amplicon generated from
serum of the index case showed 100 per cent similarity to the N gene sequence of one of the outbreak
isolates, Sydney.AUS/4.03 (data not shown). The
Genbank Accession numbers of the four sequences
from this outbreak are DQ852617, DQ852618,
DQ852619 and DQ852620.

PHU follow-up also involved providing information to
contacts who had attended church with an infectious
case. The church community of more than 500 members was provided with information in Arabic about
the risk of measles, disease symptoms, and vaccination. A beauty salon and child-care centre were
also contacted and provided with the same advice.

Discussion

The hospital infection control team undertook contact tracing of 34 staff members who had possible
exposure to measles and were in the risk age group
of between 18 and 32 years. Seventeen of these
staff members (50%) received MMR vaccination as
a result. The remainder had either a past history of
measles or measles serology indicating immunity. A
staff health program recommending MMR vaccination
was implemented at the hospital, targeting staff born
after 1970. Information and education about measles
and MMR vaccination were distributed by letter to
susceptible staff, and to all staff through hospital
networks including a staff newsletter and electronically. MMR vaccination was also offered at different
locations throughout the hospital. Only 17 per cent of
staff born after 1970 (134 out of 788 people identified
from staff records) took the opportunity to receive
MMR vaccination with 15 per cent of staff declining
and 62 per cent not responding to the program. Only

This paper describes a cluster of nine laboratoryconfirmed cases of measles, eight of which were
linked through contact. The index case had returned
from Nepal three days prior to onset of fever and
seven days prior to onset of rash. As the incubation
time for measles is about 10 days, varying from 7 to
18 days to onset of fever and 14 days to onset of
rash,6 the most likely scenario is that the disease
was acquired in Nepal. Phylogenetic analyses of
the N and H regions of the measles viruses isolated
from four cases indicated that sequences were most
closely related to each other and the Janakpur.
NEP/2.99/1 strain, a genotype D8 isolate of
Nepalese origin,16 further suggesting the acquisition
of measles in Nepal and transmission to contacts
in Australia. As outbreaks of measles become rarer
in countries where vaccination programs have been
effective, it is important to thoroughly investigate any
incursions of disease. Genetic analysis of measles
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Figure 2. Phylogenetic relationship based on the carboxy terminal end of the N gene (456nt) of the
four Sydney isolates to recent isolates, Janakpur.NEP/2.99/1,16 MVi/Kampala.UGA/51.00.1,13 and
other reference strains quoted by the WHO.12
Edmonston wt.USA/54 [A]
Goettingen.DEU/71 [E]
Tokyo.JPN/84/K [C1]
100

Erlangen.DEU/90 [C2]
Maryland.USA/77 [C2]

MVs/Madrid.SPA/94 SSPE [F]
Berkeley.USA/83 [G1]
Amsterdam.NET/49.97 [G2

96.1

89.6

Gresik.INO/17.02 [G3]
Hunan.CHN/93/7 [H1]

96.9

Beijing.CHN/94/1 [H2]
Manchester.UNK/30.94 [D8]

99.1

Janakpur.NEP/2.99/1 [D8]
95.9
99.9

Sydney.AUS/4.03
Sydney.AUS/2.03
Sydney.AUS/6.03
Sydney.AUS/5.03

77.2

Illinois.USA/50.99 [D7]
Victoria.AUS/16.85 [D7]
Illinois.USA/89/1 [D3]
Montreal.CAN/89 [D4]
Victoria.AUS/12.99 [D9]
Bangkok.THA/93/1 [D5]
Palau.BLA/93 [D5]
Bristol.UNK/74 (MVP) [D1]
New Jersey.USA/94/1 [D6]
Johannesburg.SOA/88/1 [D2]
MVi/Kampala.UGA/51.00.1 [D10]
Libreville.GAB/84 [B2]
Yaounde.CAE/12.83 [B1]

95.7

Ibadan.NIE/97/1 [B3]
New York.USA/94 [B3]
0.01

Significant bootstrap values are indicated at the nodes (1,000 replicates, in %) of the unrooted tree. The isolates from this cluster
are shown in bold. The scale indicates 1 per cent nt difference and [ ] denotes the genotypes of the reference strains.

isolates can aid in identifying the geographic and
personal source of the outbreak, confirm relatedness of cases within outbreaks, and identify routes
of transmission.13,18
An interesting aspect of this cluster was the occurrence of measles in a 2-month-old baby whose
17-year-old mother was immune. In most cases,
maternal antibodies from measles infection or
vaccination will protect newborns. Antibody levels
wane after 6 to 9 months and measles vaccination
is offered at 9 to 12 months in most countries. It has
been suggested that infants of women who have
received measles vaccine may experience earlier
loss of maternal antibody than infants whose mothers were immune due to natural infection.19 This may
result in insufficient protection for these children

CDI

Vol 30

No 3

2006

prior to their scheduled vaccination. The mother of
the infant in this case thought she had contracted
measles when aged five years and living overseas.
She also recalled missing a high school vaccination.
It is therefore likely that her immunity was due to
natural disease and, accordingly, her infant would
be expected to have passive immunity. The fact that
the child developed measles indicates that a diagnosis of measles in a very young child presenting
with measles-like symptoms, although unexpected,
should not be discounted. An interesting feature of
the infant’s illness was a short incubation period with
the rash appearing only eight days after exposure.
Incubation periods for measles are typically shorter
in children.20
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The index case did not have a documented history
of measles vaccination and was in an age group
at higher risk. The lack of documented vaccination
history amongst all but one case reinforces the
importance of vaccination as a protective measure
against the disease. Furthermore, patient recall of
vaccination or disease cannot be relied upon as
sufficient evidence. In this outbreak the index case
claimed to have been vaccinated and to have had
clinical measles. These claims may have reduced
the index of suspicion of measles in the Emergency
Department despite the classical measles symptoms
and recent travel history. The claims are also a likely
reason for lack of MMR vaccination prior to travel
to a measles-endemic area. The National Health
and Medical Research Council recommends MMR
vaccination for travellers born during or since 1966
who have not received two doses of MMR vaccine.21
The importance of documented history of vaccination rather than patient recall should be emphasised
to potential travellers seeking advice about travel
vaccination.
One child in this cluster (Case 4) could have
received MMR vaccination shortly after exposure,
an action that may have prevented the disease.
However, despite advice from the PHU, the child
was not vaccinated and subsequently developed
measles. Transmission within the Emergency
Department played a significant role in this outbreak
with contact at that site being responsible for five
cases. The highly infectious nature of measles was
demonstrated by the development of measles in a
staff member who did not come into contact with the
patient, but who entered the room fifteen minutes
after it had been vacated. Guidelines from NSW
Health indicate that susceptible persons should not
have entered the room for two hours after the infectious case had left.6 On the other hand, a properly
protected workforce would obviate the need for such
measures to protect staff and would allow hospital
resources to be used efficiently. Healthcare workers should be aware of their vaccination status and
ensure their vaccinations are up-to-date. The issues
of nosocomial transmission of measles and the
need for staff vaccination are not new.22,23 However
their importance is not always reflected in a proactive approach by healthcare workers to ensure
they are properly protected. At this hospital, some
staff members in the age group at higher risk were
reluctant to be vaccinated with MMR, even after
two colleagues had contracted measles at work.
Programs to promote MMR vaccination to staff during and after the outbreak were poorly patronised by
clinical staff, with a better response from non-clinical
staff. Studies of healthcare workers have attributed
poor uptake of influenza vaccine to factors including
a lack of awareness of its importance and concern
about side effects,24 and a perception that the health
care worker was ‘healthy’ and did not need the vac-
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cine.26 If the same or similar reasons are responsible
for poor uptake of MMR vaccine amongst hospital
staff, a strong promotional campaign backed by
institutional strategies is needed to address the
problem.
Clearly, crowded hospital environments such as
Emergency Departments are risky places in terms of
transmission of airborne diseases and this outbreak
highlights the need for appropriate infection control
procedures in the event of suspected measles.
Such infection control policies and procedures are
of increasing importance in the effective management of disease outbreaks, and to respond to the
emergence of novel viral diseases such as severe
acute respiratory syndrome, and avian influenza.
The delay in diagnosis and confirmation of the index
case was problematic as it resulted in delayed contact tracing and follow-up. With low rates of measles
notifications in Australia, the improbability of measles as a diagnosis may result in delays in laboratory testing and diagnosis, quarantine of the case,
and contact tracing, vaccination or immunoglobulin
treatment. Until measles is eradicated, vigilance is
required amongst physicians treating patients who
present with a rash, or who have recently returned
from overseas. Early action in notifying public health
authorities and infection control staff, and the timely
provision of immunoglobulin or MMR vaccination to
those at risk are crucial steps in minimising the risk
of secondary cases.
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